Clinical Trial Update: A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects [Phase 2]

View source ↗

Summary

This update reports the results of a Phase 2 study evaluating the effect of adding leptin to pramlintide on body weight in overweight and obese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Leptin (leptin)
• pramlintide (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Overweight, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2014-02-28